What Transformation Has the Viscosupplementation Market Undergone?
The viscosupplementation market has seen considerable growth due to a variety of factors.
• The market size of viscosupplementation has seen a swift escalation in the recent past, and it's projected to expand from <$4.1 billion in 2024 to $4.55 billion in 2025, growing at a compound annual growth rate (CAGR) of 10.8%. The experienced growth during the historical period can be credited to factors such as an aging demographic, increasing obesity numbers, improved insurance policies, rising awareness, patient choice, and a surge in osteoarthritis cases.
What Are The Predictions for The Viscosupplementation Market?
The Viscosupplementation market is expected to maintain its strong growth trajectory in upcoming years.
• In the upcoming years, a swift enlargement is anticipated for the viscosupplementation market, projected to reach $6.81 billion in 2029, expanding at a compound annual growth rate (CAGR) of 10.6%.
Several factors like regulatory backing, various payment patterns, growth in healthcare spending, research and development initiatives, and expansion of indications are contributing to this development during the predicted period. Predominant trends for this period incorporate outcome-centric payment models, patient awareness programs, biomarker advancements, gene therapy studies, and value-oriented care models.
Which Drivers Are Accelerating Growth In The Viscosupplementation Market?
The anticipated increase in osteoarthritis cases is forecasted to stimulate the expansion of the viscosupplementation market. Osteoarthritis is a degenerative joint disorder, also identified as a widespread type of arthritis, where the joints begin to deteriorate, primarily in the hips, knees, and hands. Viscosupplementation therapy aids in alleviating pain and promoting easy bone movement through the injection of hyaluronic acid directly into the bone joints. This procedure assists in lessening pain and enhancing bone function. For example, the Centers for Disease Control and Prevention (CDC), a public health organization based in the U.S., states that by 2040, 78.4 million adults aged 18 and above in the U.S. will likely be diagnosed with arthritis. Consequently, the projected increase in osteoarthritis cases is propelling the expansion of the viscosupplementation market.
What Are The Core Segments Of The Global Viscosupplementation Market?
The viscosupplementation market covered in this report is segmented –
1) By Type: Single Injection Viscosupplementation, Three Injection Viscosupplementation, Five Injection Viscosupplementation
2) By Source: Avian Origin, Non-Avian Origin
3) By Hyaluronic Acids: Standard Hyaluronic Acid, Stabilized Hyaluronic Acid
4) By Application: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis
5) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Single Injection Viscosupplementation: Hyaluronic Acid-Based Products, Non-Hyaluronic Acid Products
2) By Three Injection Viscosupplementation: Hyaluronic Acid-Based Products, Combination Products
3) By Five Injection Viscosupplementation: Hyaluronic Acid-Based Products, Combination Products
Pre-Book The Viscosupplementation Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Trends Are Reshaping The Viscosupplementation Market Size?
Leading organizations in the viscosupplementation market are striving to innovate, creating pioneering products such as reabsorbable, hyaluronic acid structures. These improvements aim to increase joint suppleness, encourage tissue renewal, and offer lasting alleviation from symptoms of osteoarthritis. In this way, they seek to improve patient experiences and broaden the treatments available. Reabsorbable hyaluronic acid structures are both biocompatible and biodegradable, primarily manufactured from hyaluronic acid (HA), a polysaccharide naturally found in connective tissues. For example, in May 2023, a US firm specialized in orthopedics, Anika Therapeutics, Inc., launched Hyalofast, an instantly available, one-stage, reabsorbable, hyaluronic acid structure designed for cartilage repair. Hyalofast is a hyaluronic acid-based solution devised with a focus on preserving joints and could propose an alternate option to more invasive surgical procedures.
Who Are the Key Players In The Viscosupplementation Market?
Major companies operating in the viscosupplementation market include:
• Seikagaku Corporation
• Anika Therapeutics Inc.
• Bioventus LLC
• Zimmer Biomet
• Johnson & Johnson Services Inc.
• Aptissen S.A.
• Smith & Nephew Plc.
• Flexion Therapeutics Inc.
• Regen Lab SA
• OrthogenRx Inc.
• Fidia Farmaceutici S.P.A
• Ferring Pharmaceuticals
• Laboratoires VIVACY
• Allergan
• Hyalgan
• Synvisc
• Euflexxa
• Sanofi S.A.
• Wellchem Pharmaceuticals Pte Ltd.
• SingHealth Group
What Are The Regional Insights Into The Viscosupplementation Market?
North America was the largest region in the viscosupplementation market in 2024. The regions covered in the viscosupplementation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
